Keros Therapeutics (KROS) Stock Chart & Stock Price History $14.32 0.00 (0.00%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$14.32 -0.01 (-0.03%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Keros Therapeutics Stock Price Performance The Keros Therapeutics (KROS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 70.86%, with a year-to-date return of -9.54%. In the past month, the stock has increased 6.79%, reflecting recent market activity. As of the latest close, Keros Therapeutics traded at $14.32 with a market cap of $581.61 million and volume of 261,048 shares. Five years ago, the stock traded at $32.10, representing a 55.39% decrease over that period. At the time, it had a market cap of $587.21 million and a volume of 49,609 shares. Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.31%1 Month Performance+6.79%3 Month Performance-2.25%Year-To-Date Performance-9.54%1 Year Performance-70.86%5 Year Performance-55.39% KROS Stock Chart for Saturday, August, 2, 2025 KROS Chart by TradingView Keros Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$14.32$14.32$14.50$14.25261,048 shs$581.61 million07/31/2025$14.47$14.32-1.04%$14.48$14.25425,945 shs$581.68 million07/30/2025$14.48$14.47-0.07%$14.81$14.35379,511 shs$587.77 million07/29/2025$14.51$14.48-0.21%$14.60$14.42266,556 shs$588.11 million07/28/2025$14.46$14.51+0.35%$14.66$14.45312,824 shs$589.40 million07/25/2025$14.38$14.46+0.56%$14.72$14.18324,817 shs$587.37 million07/24/2025$14.43$14.38-0.35%$14.74$14.19287,734 shs$584.12 million07/23/2025$13.73$14.43+5.10%$14.85$13.701.05 million shs$586.07 million07/22/2025$13.79$13.73-0.44%$14.09$13.71366,642 shs$557.71 million07/21/2025$13.75$13.79+0.29%$14.39$13.75499,955 shs$560.15 million Get the Latest News and Ratings for KROS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$14.36$13.75-4.25%$14.52$13.65458,344 shs$558.53 million07/17/2025$14.49$14.36-0.90%$14.70$14.33737,776 shs$583.30 million07/16/2025$14.25$14.49+1.68%$14.58$14.18377,232 shs$588.51 million07/15/2025$14.57$14.25-2.20%$14.75$14.19247,818 shs$578.84 million07/14/2025$14.44$14.57+0.90%$14.83$14.44366,707 shs$591.83 million07/11/2025$14.47$14.44-0.21%$14.60$14.34351,432 shs$586.55 million07/10/2025$14.32$14.47+1.05%$14.66$14.11592,601 shs$587.70 million07/09/2025$13.91$14.32+2.95%$14.68$13.93599,913 shs$581.68 million07/08/2025$13.40$13.91+3.81%$14.08$13.39796,888 shs$565.02 million07/07/2025$13.33$13.40+0.53%$13.54$13.26517,755 shs$544.31 million07/04/2025$13.33$13.33$13.69$13.38148,107 shs$541.47 million07/03/2025$13.41$13.33-0.60%$13.69$13.38148,107 shs$541.40 million07/02/2025$13.34$13.41+0.52%$13.77$13.24414,700 shs$544.71 million07/01/2025$13.35$13.34-0.07%$13.64$13.30379,362 shs$541.87 million Related Companies Agios Pharmaceuticals Stock Price Chart Arrowhead Pharmaceuticals Stock Price Chart IDEAYA Biosciences Stock Price Chart Mesoblast Stock Price Chart Beam Therapeutics Stock Price Chart Harmony Biosciences Stock Price Chart Twist Bioscience Stock Price Chart Disc Medicine Stock Price Chart Denali Therapeutics Stock Price Chart Centessa Pharmaceuticals Stock Price Chart Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KROS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keros Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Keros Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
